Olema Pharmaceuticals slides 8% to 52-week low
Market Movers·
Olema Pharmaceuticals
OLMA6.4108.69% ( -0.610 )
Closed: Oct 23, 16:00:00 (EDT)Corning, Cellectis, Biodexa Pharmaceuticals And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
benzinga_article·- U.S. stock futures declined during Monday's pre-market session, with Nasdaq 100 futures dropping by approximately 500 points. - Several major stocks experienced significant downward movements following announcements of corporate offerings, strategic shifts, or financial results. - Corning shares fell 8% to $ 153.05 after announcing a $ 2 billion offering, while Cellectis dropped 19.4% following a strategic transformation approval.Olema Maintained at Buy as Analyst Sees Post-SERENA-4 Pullback as Opportunity, Reiterates $59 Price Target
Tip Ranks·- Citi analyst Yigal Nochomovitz maintained a buy rating on Olema Pharmaceuticals with an unchanged price target of 59.00 USD. - The analyst views the post-SERENA-4 stock pullback as an attractive entry point because the current valuation undervalues its breast cancer business. - Additional supporting factors include the strong fundamentals of palazestrant and upcoming catalysts like the OPERA-01 Phase 3 results in early 2027.